Search

New research shows that immune cells developed from early exposure to bacteria contribute to vision loss in glaucoma patients. A research team from Harvard Ophthalmology and MIT has shown that immune cells in the eye that developed in response to early exposure to bacteria are a key contributor to...

Researchers have developed a potential new strategy for improving outcomes in corneal transplant surgeries by injecting vasoactive intestinal peptide into the eye. A new study led by Harvard Ophthalmology faculty reports for the first time that injection of the neuropeptide vasoactive intestinal...

Rosario Fernandez-Godino, PhD, MSc, has been selected to receive the BrightFocus Foundation Award. The award, presented by the foundation’s Macular Degeneration Research Program to investigators who have generated promising preliminary data on potential treatments for macular degeneration, will...

A study led by Eleftherios Paschalis, PhD, describes a mechanism by which patients with acute ocular injuries become susceptible to progressive neurodegeneration long after the injury has taken place. Published in Proceedings of National Academy of Sciences, Dr. Paschalis and colleagues demonstrate...

In Nature, Luk Vandenberghe, PhD, Harvard Medical School Associate Professor of Ophthalmology and Director of the Grousbeck Gene Therapy Center at Mass. Eye and Ear, discusses increasing the efficiency of gene therapies by manipulating the viral vectors that transport genes into cells. He also talks...

Patricia A. D’Amore, PhD, MBA, the Charles L. Schepens Professor of Ophthalmology at Harvard Medical School (HMS), Vice Chair for Basic and Translational Research at HMS, and Co-Director of the Harvard Ophthalmology AMD Center of Excellence, received the Barbara McNeil Award for Exceptional Service...